HIVRT Scholars

A medical doctor and health informatics expert driving digital transformation in African healthcare. With over 16 years of experience, he leads national projects, mentors students, and develops innovative health software to improve systems and save lives.

Post-doctoral fellow at UB-UZ HRTP and clinical pharmacologist at the University of Zimbabwe. His PhD research on herbal anticancer properties won awards at AMRD (2024). His post-doctoral work will focus on HIV-related cancers and ethnomedicine, advancing healthcare and supporting UN Sustainable Development Goal Three.

With over a decade of experience in clinical research and a PhD in Translational Medicine, her career bridges laboratory science and healthcare delivery, focusing on improving outcomes for people living with HIV and non-communicable diseases.

A dedicated PhD scientist from the University of Zimbabwe, transforming lives through impactful research on HIV, pediatric schistosomiasis, and inflammation — bringing hope to vulnerable communities and driving public health change.

Biomedical scientist and lecturer at the University of Zimbabwe specializing in Clinical Biochemistry. As a DPhil student, she researches insulin resistance and genomic risk in adults with HIV on dolutegravir, aiming to improve pharmacovigilance and care.

A DPhil candidate advancing HIV care through ARV nano-formulations. With international training in nanoparticle science, they are developing ARV assays for a leading pharmacology lab in Zimbabwe.

Public health specialist and medical laboratory scientist with over 10 years at Zimbabwe’s Ministry of Health, now pursuing a PhD in HIV Clinical Pharmacology and Therapeutics. Her research examines pharmacogenetics and neuropsychiatric effects of dolutegravir in people with HIV. With a Master’s in Public Health and four publications, she champions evidence-based interventions in resource-limited settings.